| Title |
Lifestyle interventions for acute gout
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2013
|
| DOI | 10.1002/14651858.cd010519.pub2 |
| Pubmed ID | |
| Authors |
John HY Moi, Melonie K Sriranganathan, Christopher J Edwards, Rachelle Buchbinder |
| Abstract |
Although lifestyle interventions are often recommended in the management of chronic gout, the evidence from trial data of the benefits and safety of using lifestyle interventions for treating acute gout attacks have not previously been examined in a systematic review. |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 29% |
| United Kingdom | 3 | 18% |
| Australia | 2 | 12% |
| Malaysia | 1 | 6% |
| India | 1 | 6% |
| Unknown | 5 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 76% |
| Practitioners (doctors, other healthcare professionals) | 3 | 18% |
| Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 253 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Ireland | 1 | <1% |
| Canada | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 249 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 42 | 17% |
| Student > Master | 40 | 16% |
| Student > Ph. D. Student | 23 | 9% |
| Researcher | 18 | 7% |
| Student > Postgraduate | 15 | 6% |
| Other | 47 | 19% |
| Unknown | 68 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 92 | 36% |
| Nursing and Health Professions | 29 | 11% |
| Psychology | 12 | 5% |
| Agricultural and Biological Sciences | 7 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
| Other | 23 | 9% |
| Unknown | 83 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2016.
All research outputs
#2,635,448
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#5,216
of 11,499 outputs
Outputs of similar age
#24,100
of 228,133 outputs
Outputs of similar age from Cochrane database of systematic reviews
#113
of 235 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,133 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 235 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.